Wang Tianyi, Li Hangyu, Feng Shixing, Wang Junqi, Qin Wanli, Zhang Yuan, Sun Wen, Wang Chenlu, Cai Xuanyi, Han Dongran, Liu Jialin, Liu Yixing
School of Management, Beijing University of Chinese Medicine, Beijing, China.
School of Life and Science, Beijing University of Chinese Medicine, Beijing, China.
Front Cardiovasc Med. 2023 Dec 14;10:1147135. doi: 10.3389/fcvm.2023.1147135. eCollection 2023.
BACKGROUND: Hypertension has now developed into a major public health problem worldwide. Under the existing antihypertensive drug treatment paradigm, problems such as decreasing drug resistance and increasing drug side effects can occur for elderly patients. Acupuncture, a core technique in the non-pharmacological treatment of Chinese medicine, plays an important role in the treatment of elevated blood pressure. OBJECTIVE: This study aimed to systematically evaluate the effect of acupuncture alone or in combination with antihypertensive drugs on the efficiency of reducing blood pressure and controlling blood pressure in elderly patients with hypertension. METHODS: Articles of randomized controlled trials of acupuncture for hypertension in the elderly published before November 2022 were searched in 7 databases. The methodological quality of the literature was evaluated using the Cochrane Risk of Bias Assessment Tool. The primary outcome was the efficiency rate of blood pressure reduction, and the secondary outcome was the change in blood pressure after treatment. RESULTS: This study conducted a systematic review and meta-analysis of 12 randomized controlled trials with a total of 1,466 subjects. Among the primary outcome-efficiency rate, acupuncture-only treatment (RR = 1.11, 95% CI: 1.03-1.20, < 0.01) and acupuncture combined with antihypertensive drug treatment (RR = 1.18, 95% CI: 1.06-1.31, < 0.01) were significantly different compared with drugs-only treatment. Among the secondary outcomes, SBP (MD: -4.85, 95% CI: -10.39 to -0.69, = 0.09) and DBP (MD: -1.45, 95% CI: -5.35 to 2.45, = 0.47) show no significant difference between acupuncture-only treatment and drug-only treatment. Compared to drugs-only treatment, acupuncture plus drugs has more significant efficiency in lowering SBP (MD: -9.81, 95% CI: -13.56 to -6.06, < 0.01) and DBP (MD: -7.04, 95% CI: -10.83 to -3.24, < 0.01). CONCLUSION: For elderly patients with hypertension, acupuncture-only treatment has the same efficiency and antihypertensive effect compared to drug therapy and acupuncture plus drugs outperforms drugs-only treatment. If the patients receive therapy with less frequency per week and longer duration, there will be a more obvious antihypertensive effect. Due to the methodological defects in the included study and the limited sample size of this paper, more well-designed randomized controlled trials are needed for verification. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022376407, PROSPERO (CRD42022376407).
背景:高血压现已发展成为全球主要的公共卫生问题。在现有的降压药物治疗模式下,老年患者可能会出现耐药性降低和药物副作用增加等问题。针灸作为中医非药物治疗的核心技术,在高血压治疗中发挥着重要作用。 目的:本研究旨在系统评价单独针刺或针刺联合降压药物对老年高血压患者降压疗效和血压控制的影响。 方法:检索7个数据库中2022年11月以前发表的关于针刺治疗老年高血压的随机对照试验文献。采用Cochrane偏倚风险评估工具对文献的方法学质量进行评价。主要结局为血压降低有效率,次要结局为治疗后血压变化。 结果:本研究对12项随机对照试验进行了系统评价和Meta分析,共纳入1466例受试者。在主要结局有效率方面,单纯针刺治疗(RR = 1.11,95%CI:1.03 - 1.20,P < 0.01)和针刺联合降压药物治疗(RR = 1.18,95%CI:1.06 - 1.31,P < 0.01)与单纯药物治疗相比有显著差异。在次要结局方面,单纯针刺治疗与单纯药物治疗相比,收缩压(MD:-4.85,95%CI:-10.39至-0.69,P = 0.09)和舒张压(MD:-1.45,95%CI:-5.35至2.45,P = 0.47)无显著差异。与单纯药物治疗相比,针刺加药物在降低收缩压(MD:-9.81,95%CI:-13.56至-6.06,P < 0.01)和舒张压(MD:-7.04,95%CI:-10.83至-3.24,P < 0.01)方面效率更高。 结论:对于老年高血压患者,单纯针刺治疗与药物治疗具有相同疗效和降压效果,针刺联合药物治疗优于单纯药物治疗。若患者接受治疗的频率较低且疗程较长,降压效果将更明显。由于纳入研究存在方法学缺陷且本文样本量有限,尚需更多设计良好的随机对照试验进行验证。 系统评价注册:https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022376407,PROSPERO(CRD42022376407)
Front Cardiovasc Med. 2023-12-14
Cochrane Database Syst Rev. 2022-2-1
Front Neurol. 2023-5-26
Front Neurol. 2023-11-16
Cochrane Database Syst Rev. 2018-11-14
Front Neurol. 2023-1-12
Complement Ther Clin Pract. 2022-11
Front Biosci (Landmark Ed). 2021-12-30
Am J Chin Med. 2020-3-5
Complement Ther Clin Pract. 2017-11-8
Hypertension. 2018-2